Occam’s Board Practice Continues to Flourish
Occam Global placed Josh Ofman, MD, as Chairman of the Board of EveryONE Medicines in July 2024. The company was founded with seed financing from Khosla Ventures, GV, and Third Rock Ventures to develop treatments tailored to individual patients with ultra-orphan diseases.
Ofman is the President of GRAIL, a publicly-traded Illumina spinout backed by ARCH Venture Partners, Bezos Expeditions, Bill Gates, and Sutter Hill Ventures. He spent more than 15 years at Amgen, where he most recently held the role of Senior Vice President, Global Value, Access, and Policy.
Josh holds a BA in history and philosophy of science from the University of California, Berkeley, and an MD from theUniversity of California, Irvine, School of Medicine.
Recent Placements
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.